Found 5 matching trials
BRIDGE Study: Neoadjuvant Finotonlimab, Cetuximab, and Docetaxel in Resectable Recurrent HNSCC After Immunotherapy Progression
PHASE2This is a multicenter, single-arm, phase II clinical study evaluating the e...
Status
Enrolling By Invitation
Location
The First People's Hospital of Foshan
SCT-I10A Plus Standard Chemotherapy in First-line Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma
PHASE3The objective of this study is to evaluate the efficacy and safety of SCT-I...
Location
The Third Affiliated Hospital Of Qiqihar Medical University
SCT200 in Combination With SCT-I10A/Paclitaxel/Docetaxel in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
PHASE1The study is to explore the efficacy and safety of SCT200 with SCT-I10A or ...
Location
Shanghai East Hospital
Study of SCT-I10A Combined SCT200 or SCT-I10A Combined SCT200 Plus Chemotherapy in ESCC and CRC
PHASE1The purpose of this study is to evaluate the safety and efficacy of SCT-I10...
Location
Multiple Locations
Safety and Efficacy of SCT-I10A in Head and Neck Squamous Cell Carcinoma
PHASE2The objective of this study is to evaluate the efficacy and safety of SCT-I...
Location
Guangxi Medical University Affiliated Tumour Hospital